CME Group (CME Group) GF Value : $232.56 (As of Apr. 27, 2024)

View and export this data going back to 2002. Start your Free Trial

What is CME Group GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-27), CME Group's share price is $210.94. CME Group's GF Value is $232.56. Therefore, CME Group's Price-to-GF-Value for today is 0.91.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes CME Group is Fairly Valued.

CME Group (NAS:CME) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

CME Group's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	210.94	/	232.56
	=	0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CME Group GF Value Related Terms

Thank you for viewing the detailed overview of CME Group's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

CME Group (CME Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » CME Group Inc (NAS:CME) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

CME:Mexico MX4A:Germany MX4A:Germany CHME34:Brazil

Address

20 South Wacker Drive, Chicago, IL, USA, 60606

Website

https://www.cmegroup.com

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.

Executives

William R Shepard	director	20 S. WACKER DR, CHICAGO IL 60606
Bryan T Durkin	officer: MD & COO	20 S. WACKER DRIVE, CHICAGO IL 60606
Derek Sammann	officer: Managing Dir Financial Product	20 S. WACKER DRIVE, CHICAGO IL 60606
Dennis Suskind	director	ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Suzanne Sprague	officer: Sr MD Global Head of Clearing	20 SOUTH WACKER DRIVE, 18S, CHICAGO IL 60606
Timothy Francis Mccourt	officer: Sr MD Global Head Equity & FX	20 S WACKER DRIVE, CHICAGO IL 60606
Elizabeth A Cook	director	20 S. WACKER DRIVE, CHICAGO IL 60606
Martin J Gepsman	director	20 S. WACKER DR, CHICAGO IL 60606
Terrence A Duffy	director	20 S. WACKER DR, CHICAGO IL 60606
Julie Holzrichter	officer: MD Operations	20 S. WACKER DRIVE, CHICAGO IL 60606
Timothy S. Bitsberger	director	20 S. WACKER DRIVE, CHICAGO IL 60606
Julie Winkler	officer: Chief Commercial Officer	20 S. WACKER DR., CHICAGO IL 60606
Daniel R Glickman	director	20 S. WACKER DR, CHICAGO IL 60606
Hilda Harris Piell	officer: MD, Organizational Development	20 S. WACKER DRIVE, CHICAGO IL 60606
Sunil Cutinho	officer: President, CME Clearing	20 S. WACKER DR., CHICAGO IL 60606